マーケットレポート詳細
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
血液検査の世界市場規模は2022年で46億ドル、2031年に76億ドル、市場の平均年成長率は5.6%になると予測されています。
当レポートでは、血液検査の市場予測-2031年、各種セグメント別市場分析(製品タイプ別、エンドユーザー別、国地域別、等)、パイプライン分析、COVID-19の影響分析、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。
【レポート構成概要】
・市場規模(US$)
血液学機器
・血球計数装置
-全自動血球計数装置
-半自動血球計数装置
・フローサイトメーター
・その他
血液学用消耗品
・試薬
・染色剤
・コントロール/キャリブレーター
・その他
※(市場規模US$)
診断研究所
病院/クリニック
学術機関
その他
※(市場規模US$)
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア/ニュージーランド
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照
市場ダイナミクス(促進要因、障壁、機会)
パイプライン分析
COVID-19の影響分析
競合状況
市場シェア分析
SWOT分析
Abbott
シスメックス株式会社
F. Hoffmann-La Roche Ltd.
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Siemens Healthineers AG
株式会社堀場製作所
HemoCue AB
Danaher Corporation
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Hematology Diagnostics Market Analysis and Forecast, 2023–2031
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2023–2031
6.3.1. Hematology Instruments
6.3.1.1. Hematology Analyzers
6.3.1.1.1. Fully-automated Hematology Analyzers
6.3.1.1.2. Semi-automated Hematology Analyzers
6.3.1.2. Flow Cytometers
6.3.1.3. Others
6.3.2. Hematology Consumables
6.3.2.1. Reagents
6.3.2.2. Stains
6.3.2.3. Controls & Calibrators
6.3.2.4. Others
6.4. Market Attractiveness Analysis, by Product Type
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2023–2031
7.3.1. Diagnostic Laboratories
7.3.2. Hospitals & Clinics
7.3.3. Academic Institutes
7.3.4. Others
7.4. Market Attractiveness Analysis, by End-user
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2023–2031
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9.1. Introduction
9.2. Key Findings
9.3. Market Value Forecast, by Product Type, 2023–2031
9.3.1. Hematology Instruments
9.3.1.1. Hematology Analyzers
9.3.1.1.1. Fully-automated Hematology Analyzers
9.3.1.1.2. Semi-automated Hematology Analyzers
9.3.1.2. Flow Cytometers
9.3.1.3. Others
9.3.2. Hematology Consumables
9.3.2.1. Reagents
9.3.2.2. Stains
9.3.2.3. Controls & Calibrators
9.3.2.4. Others
9.4. Market Value Forecast, by End-user, 2023–2031
9.4.1. Diagnostic Laboratories
9.4.2. Hospitals & Clinics
9.4.3. Academic Institutes
9.5. Market Value Forecast, by Country, 2023–2031
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Product Type
9.6.2. By End-user
9.6.3. By Country
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product Type, 2023–2031
10.3.1. Hematology Instruments
10.3.1.1. Hematology Analyzers
10.3.1.1.1. Fully-automated Hematology Analyzers
10.3.1.1.2. Semi-automated Hematology Analyzers
10.3.1.2. Flow Cytometers
10.3.1.3. Others
10.3.2. Hematology Consumables
10.3.2.1. Reagents
10.3.2.2. Stains
10.3.2.3. Controls & Calibrators
10.3.2.4. Others
10.4. Market Value Forecast, by End-user, 2023–2031
10.4.1. Diagnostic Laboratories
10.4.2. Hospitals & Clinics
10.4.3. Academic Institutes
10.4.4. Others
10.5. Market Value Forecast, by Country/Sub-region, 2023–2031
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By End-user
10.6.3. By Country/Sub-region
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product Type, 2023–2031
11.3.1. Hematology Instruments
11.3.1.1. Hematology Analyzers
11.3.1.1.1. Fully-automated Hematology Analyzers
11.3.1.1.2. Semi-automated Hematology Analyzers
11.3.1.2. Flow Cytometers
11.3.1.3. Others
11.3.2. Hematology Consumables
11.3.2.1. Reagents
11.3.2.2. Stains
11.3.2.3. Controls & Calibrators
11.3.2.4. Others
11.4. Market Value Forecast, by End-user, 2023–2031
11.4.1. Diagnostic Laboratories
11.4.2. Hospitals & Clinics
11.4.3. Academic Institutes
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-region, 2023–2031
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By End-user
11.6.3. By Country/Sub-region
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product Type, 2023–2031
12.3.1. Hematology Instruments
12.3.1.1. Hematology Analyzers
12.3.1.1.1. Fully-automated Hematology Analyzers
12.3.1.1.2. Semi-automated Hematology Analyzers
12.3.1.2. Flow Cytometers
12.3.1.3. Others
12.3.2. Hematology Consumables
12.3.2.1. Reagents
12.3.2.2. Stains
12.3.2.3. Controls & Calibrators
12.3.2.4. Others
12.4. Market Value Forecast, by End-user, 2023–2031
12.4.1. Diagnostic Laboratories
12.4.2. Hospitals & Clinics
12.4.3. Academic Institutes
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2023–2031
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By End-user
12.6.3. By Country/Sub-region
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product Type, 2023–2031
13.3.1. Hematology Instruments
13.3.1.1. Hematology Analyzers
13.3.1.1.1. Fully-automated Hematology Analyzers
13.3.1.1.2. Semi-automated Hematology Analyzers
13.3.1.2. Flow Cytometers
13.3.1.3. Others
13.3.2. Hematology Consumables
13.3.2.1. Reagents
13.3.2.2. Stains
13.3.2.3. Controls & Calibrators
13.3.2.4. Others
13.4. Market Value Forecast, by End-user, 2023–2031
13.4.1. Diagnostic Laboratories
13.4.2. Hospitals & Clinics
13.4.3. Academic Institutes
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2023–2031
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By End-user
13.6.3. By Country/Sub-region
14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2022)
14.3. Company Profiles
14.3.1. Abbott
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Financial Overview
14.3.1.5. Strategic Overview
14.3.2. Sysmex Corporation
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Financial Overview
14.3.2.5. Strategic Overview
14.3.3. F. Hoffmann-La Roche Ltd.
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Financial Overview
14.3.3.5. Strategic Overview
14.3.4. Beckman Coulter, Inc.
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Financial Overview
14.3.4.5. Strategic Overview
14.3.5. Bio-Rad Laboratories, Inc.
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Financial Overview
14.3.5.5. Strategic Overview
14.3.6. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Financial Overview
14.3.6.5. Strategic Overview
14.3.7. Siemens Healthineers AG
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Financial Overview
14.3.7.5. Strategic Overview
14.3.8. Horiba, Ltd.
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Financial Overview
14.3.8.5. Strategic Overview
14.3.9. HemoCue AB
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Financial Overview
14.3.9.5. Strategic Overview
14.3.10. Danaher Corporation
14.3.10.1. Company Overview
14.3.10.2. Product Portfolio
14.3.10.3. SWOT Analysis
14.3.10.4. Financial Overview
14.3.10.5. Strategic Overview
Table 01: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2023–2031
Table 02: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2023–2031
Table 03: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by Region, 2023–2031
Table 04: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country, 2023–2031
Table 05: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2023–2031
Table 06: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2023–2031
Table 07: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2031
Table 8: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2023–2031
Table 9: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2023–2031
Table 10: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2031
Table 11: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2023–2031
Table 12: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2023–2031
Table 13: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2031
Table 14: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2023–2031
Table 15: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2023–2031
Table 16: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2023–2031
Table 17: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2023–2031
Table 18: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2023–2031
Figure 01: Global Hematology Diagnostics Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2031
Figure 02: Global Hematology Diagnostics Market Revenue (US$ Mn), by Product Type, 2022
Figure 03: Global Hematology Diagnostics Market Value Share, by Product Type, 2022
Figure 04: Global Hematology Diagnostics Market Revenue (US$ Mn), by End-user, 2022
Figure 05: Global Hematology Diagnostics Market Value Share, by End-user, 2022
Figure 06: Global Hematology Diagnostics Market Value Share, by Region, 2022
Figure 07: Global Hematology Diagnostics Market Value (US$ Mn) Forecast, 2023–2031
Figure 8: Global Hematology Diagnostics Market Value Share Analysis, by Product Type, 2023 and 2031
Figure 9: Global Hematology Diagnostics Market Attractiveness Analysis, by Product Type, 2022-2031
Figure 10: Global Hematology Diagnostics Market Value Share Analysis, by End-user, 2023 and 2031
Figure 11: Global Hematology Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031
Figure 12: Global Hematology Diagnostics Market Value Share Analysis, by Region, 2023 and 2031
Figure 13: Global Hematology Diagnostics Market Attractiveness Analysis, by Region, 2022-2031
Figure 14: North America Hematology Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031
Figure 15: North America Hematology Diagnostics Market Attractiveness Analysis, by Country, 2023–2031
Figure 16: North America Hematology Diagnostics Market Value Share Analysis, by Country, 2023 and 2031
Figure 17: North America Hematology Diagnostics Market Value Share Analysis, by Product Type, 2023 and 2031
Figure 18: North America Hematology Diagnostics Market Value Share Analysis, by End-user, 2023 and 2031
Figure 19: North America Hematology Diagnostics Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 20: North America Hematology Diagnostics Market Attractiveness Analysis, by End-user, 2022–2031
Figure 21: Europe Hematology Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031
Figure 22: Europe Hematology Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 23: Europe Hematology Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2031
Figure 24: Europe Hematology Diagnostics Market Value Share Analysis, by Product Type, 2023 and 2031
Figure 25: Europe Hematology Diagnostics Market Value Share Analysis, by End-user, 2023 and 2031
Figure 26: Europe Hematology Diagnostics Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 27: Europe Hematology Diagnostics Market Attractiveness Analysis, by End-user, 2022–2031
Figure 28: Asia Pacific Hematology Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031
Figure 29: Asia Pacific Hematology Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 30: Asia Pacific Hematology Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2031
Figure 31: Asia Pacific Hematology Diagnostics Market Value Share Analysis, by Product Type, 2023 and 2031
Figure 32: Asia Pacific Hematology Diagnostics Market Value Share Analysis, by End-user, 2023 and 2031
Figure 33: Asia Pacific Hematology Diagnostics Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 34: Asia Pacific Hematology Diagnostics Market Attractiveness Analysis, by End-user, 2022–2031
Figure 35: Latin America Hematology Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031
Figure 36: Latin America Hematology Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 37: Latin America Hematology Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2031
Figure 38: Latin America Hematology Diagnostics Market Value Share Analysis, by Product Type, 2023 and 2031
Figure 39: Latin America Hematology Diagnostics Market Value Share Analysis, by End-user, 2023 and 2031
Figure 40: Latin America Hematology Diagnostics Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 41: Latin America Hematology Diagnostics Market Attractiveness Analysis, by End-user, 2022–2031
Figure 42: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2023–2031
Figure 43: Middle East & Africa Hematology Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 44: Middle East & Africa Hematology Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2031
Figure 45: Middle East & Africa Hematology Diagnostics Market Value Share Analysis, by Product Type, 2023 and 2031
Figure 46: Middle East & Africa Hematology Diagnostics Market Value Share Analysis, by End-user, 2023 and 2031
Figure 47: Middle East & Africa Hematology Diagnostics Market Attractiveness Analysis, by Product Type, 2022–2031
Figure 48: Middle East & Africa Hematology Diagnostics Market Attractiveness Analysis, by End-user, 2022–2031